Given that p53 and PML have overlapping biological
MEFs, and the resulting cell populations were examined for PML expression and NB formation using a newly activities, it is interesting that these proteins functionally and physically interact. For example, both p53 Ϫ/Ϫ and generated monoclonal antibody that specifically recognizes several murine PML isoforms ( Figure 1A , compare PML Ϫ/Ϫ thymocytes are resistant to radiation-induced apoptosis (Lowe et , respectively) and analyzed al., 1998; Serrano et al., 1997). We have previously PML expression by immunoblotting ( Figure 2A ) and imshown that PML and NBs accumulate in senescent cells munofluorescence ( Figure 2B) . Surprisingly, neither (Ferbeyre et al., 2000) . Surprisingly, we now see that PML nor PML-containing NBs were induced in ARF Ϫ/Ϫ ARF and p53 are required for PML upregulation in reor p53 Ϫ/Ϫ MEFs in response to Ras (Figure 2A , compare sponse to oncogenic ras and that PML is a direct p53 lane 2 with lanes 4 and 6; Figure 2B , "Ras" panels), target gene. Moreover, we find that PML participates in implying that ARF and p53 are required for PML inducadditional p53-mediated programs, including reversible tion. Conversely, ARF, p53, and two well-characterized cell cycle arrest and apoptosis. These data imply that p53 targets (p21 and Mdm2) were induced in response PML is not solely an upstream regulator of p53 but also data not shown). We conclude that p53 can regulate (Supplemental Figure S1 at http://www.molecule.org/ cgi/content/full/13/4/523/DC1). Bona fide p53 targets PML expression through a conserved mechanism. contain defined p53 responsive elements (REs) in their promoters that physically associate with p53 and actip53 Controls PML mRNA Expression vate transcription (see Supplemental Table S1 on MolecWe previously showed that PML protein accumulation ular Cell's website). To assess whether PML falls into in senescent cells is accompanied by increases in PML this category, we assembled the human and mouse PML mRNA (Ferbeyre et al., 2000) . To determine whether p53 promoters from sequence information available in prican also influence PML mRNA expression, we examined vate and public databases ( Figure 5A ). We then analyzed PML transcripts in the cell types described above using them using the p53Scan program ( Figure 5A ; see Supplemental Table was substantially induced, following reintroduction of S1 on Molecular Cell's website). Similarly, a genomep53, to levels comparable to those produced by IFN wide scan for p53 consensus sites using a different treatment ( Figure 4C ). Therefore, p53 can control PML algorithm also identified putative p53 REs in the human mRNA expression in a manner comparable to an estab-PML gene (Hoh et al., 2002 could confer p53 responsiveness to a heterologous resite). Constructs that contained point mutations in all three REs were unable to respond to p53 ( Figure 5C , porter. DNA fragments containing either the murine PML promoter (sequences 4410-5189) or intron 1 (sequences compare intron 1 to RE 1,2,3 mut). Double mutant constructs retaining an intact RE3 were also nonresponsive 5246-6191) were isolated from genomic DNA and subcloned into a luciferase reporter plasmid. Next, these to p53, whereas those retaining either RE1 or RE2 responded in a manner comparable to the intron 1 control constructs were transfected into p53 Ϫ/Ϫ MEFs along with increasing concentrations of a p53 expression plasmid ( Figure 5C , compare RE 1,3 mut and RE 2,3 mut with intron 1). These data imply that RE3 does not play a and a normalization control (Figures 5B and 5C ). Of note, the murine PML promoter contains both GAS and ISRE major role in p53-mediated transactivation of the PML gene and that RE1 and RE2 have redundant activities. elements that confer IFN responsiveness to the human counterpart (Stadler et al., 1995) . In fact, IFN induced a We also asked whether p53 could physically associate with PML intronic sequences in vitro and in vivo. First, 3-fold increase in reporter activity over basal levels in cells transfected with the promoter construct but had we tested several p53 REs (murine RE1-3 and human RE4) in an electrophoretic mobility shift assay (EMSA). no effect on the intron 1 construct ( Figure 5B ). Conversely, p53 triggered a 5-fold increase in luciferase Increasing amounts of recombinant p53 protein were added to each 32 P-labeled p53 RE, and the resulting activity from the intron 1 reporter but had no effect on the promoter construct. The ability of p53 to transactiproducts were resolved on polyacrylamide gels. In all instances, we observed a shift in the migration of the vate the intron 1 reporter was more pronounced in the presence of oncogenic Ras, perhaps because Ras sigprobes in the presence of p53 ( Figure 5D ; see lanes 3 and 7 for RE1 and RE4, respectively; data not shown naling enhances p53 activity ( Figure 5B ). Similar results were also obtained in H1299 cells using the correspondfor RE2 and RE3) but not to BSA (data not shown). Moreover, addition of the p53-specific antibody pAb421 ing human promoter and intron 1 reporters (data not shown). These data imply that sequences in the intron to the reaction resulted in a supershift of the probe, confirming that the complexes in fact contained p53 1 region are largely responsible for p53 regulation of the PML gene.
( Figure 5D , see lanes 4 and 8).
To determine whether endogenous p53 occupies the We next engineered point mutations in p53 REs of the murine intron 1 reporter construct at sites known to PML promoter in vivo, we used chromatin immunoprecipitation (ChIP) to detect p53 bound to specific regions abolish p53 binding and tested their impact on p53's ability to transactivate the reporter construct ( Figure 5C of DNA in live cells. MEFs harboring a control vector or oncogenic Ras were fixed in formaldehyde to crosslink and Supplemental Table S1 on Molecular Cell's web- proteins to DNA, and the p53:DNA complexes were prein the actin promoter. Taken together, our data show that PML expression is directly regulated by p53. cipitated using a cocktail of p53 monoclonal antibodies (Flores et al., 2002) . Following purification, the released DNA was analyzed by PCR using primers that flank the PML Contributes to p53-Mediated Senescence and Cell Cycle Arrest putative p53 REs. PML intron 1 sequences were detected in immunoprecipitates from Ras-expressing cells, Depending on context, p53 can induce reversible cell cycle checkpoints, senescence, or apoptosis. Having indicating that p53 was bound to the PML gene during senescence ( Figure 5E , lane 6). As controls, the same established that PML is a direct p53 target, we then asked whether disruption of PML could interfere with procedure amplified sequences corresponding to the bona fide p53 RE in the p21 promoter but not sequences any of these p53 activities. First, we examined the contri- Ϫ/Ϫ MEFs expressing shPML showed no added defect in Ras-induced arrest comp53 protein leading to massive apoptosis and a sustained response to therapy. In contrast, p53 null lymphopared to the parental p53 Ϫ/Ϫ MEFs ( Figure 6A ). To test more directly whether PML loss can attenuate mas show little apoptosis and a poor therapeutic response. Therefore, we envisioned that these lymphomas p53 arrest functions through a downstream defect, we overexpressed p53 using a p53-deficient MEF line exwould provide an ideal setting to determine whether PML might act downstream of p53 during apoptosis pressing a temperature-sensitive p53 mutant (TSP). These cells, which also lack p21, undergo a reversible in vivo. Mice harboring p53-expressing (control) and p53 null cell cycle arrest following p53 activation ( Figure  7D ), implying that their resistance to apoptosis is not populations for PML expression and apoptosis in response to several stimuli. Consistent with our in vivo due to a global defect in p53-mediated transactivation but, at least in part, to a defect downstream of p53. results, PML was induced in wild-type MEFs following adriamycin treatment and, once again, this effect was Therefore our data demonstrate that PML can contribute to p53-mediated cell cycle arrest, premature senesp53 dependent ( Figure 7C, compare lanes 2 and 4) . Importantly, this increase is functionally relevant, as cence, and apoptosis and, together with the expression data, establish PML as a mediator of p53 tumor suppres-PML Ϫ/Ϫ cells expressing Myc showed substantial apoptotic defects following treatment with adriamycin, IR, sor functions. or 0.1% serum, albeit not to the same extent as p53 Table  For immunofluorescence assays, cells were plated on coverslips and fixed using 4% paraformaldehyde in PBS for 15 min at room S1 (available on Molecular Cell's website). To identify putative p53-response elements in the PML promoter and intron 1 regions, we temperature. After washing with PBS, cells were permeabilized for 5 min with 0.2% Triton X-100 in PBS with 0.5% normal goat serum used the p53Scan program (http://bioinformatics.med.ohio-state. edu/P53) (see Supplemental Table S1 . Inducwas produced in our laboratory using His-tagged full-length mouse
